Arcutis Biotherapeutics, Inc.
USD26.31
-0.45 (-1.68%)
CEO
Todd Franklin Watanabe
IPO Date
2020-01-31
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$27.15
Prev. Close
$26.76
Day Low
$25.83
Day High
$27.20
52W Low
$13.06
52W High
$31.77
Market Cap
$3.29B
Volume
0.42M
| -12.0 |
| 31 Dec 2023 | FY | 91.6% | -439.8% | -295.6% | -76.8% | 2.32 | 7.08 | -0.9 |
| 31 Dec 2022 | FY | 79.5% | -8449.8% | -148.6% | -69.3% | 0.97 | 11.57 | -2.6 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -69.3% | -50.6% | 0.26 | 12.09 | -5.0 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -50.1% | -45.5% | 0.02 | 12.96 | -7.4 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -41.4% | -39.2% | 0.00 | 20.33 | -19.8 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 80.3% | -37.7% | 0.00 | 19.12 | -41.0 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | 99.7% | -130.3% | -0.19 | 5.52 | -4.6 |
| 53.5 |
| 30 Sept 2025 | Q3 | 91.2% | 7.5% | 4.7% | 2.0% | 0.72 | 3.50 | 81.2 |
| 30 Jun 2025 | Q2 | 90.8% | -19.5% | -11.4% | -4.5% | 0.79 | 3.20 | -28.0 |
| 31 Mar 2025 | Q1 | 86.6% | -38.1% | -17.6% | -7.3% | 0.78 | 3.55 | -19.7 |
| 31 Dec 2024 | Q4 | 90.3% | -15.1% | -6.8% | -3.1% | 0.70 | 4.15 | -39.0 |
| 30 Sept 2024 | Q3 | 87.7% | -92.8% | -26.5% | -9.5% | 1.33 | 2.46 | -7.0 |
| 30 Jun 2024 | Q2 | 88.8% | -169.6% | -28.1% | -11.8% | 1.11 | 8.46 | -5.6 |
| 31 Mar 2024 | Q1 | 93.4% | -71.4% | -15.7% | -7.4% | 0.92 | 9.89 | -7.6 |
| 31 Dec 2023 | Q4 | 83.4% | -490.0% | -74.8% | -19.4% | 2.32 | 7.08 | -1.1 |